Yüklüyor......
Olanzapine induced neuroleptic malignant syndrome
An 18 year old male diagnosed as a case of bipolar affective disorder (BPAD), developed neuroleptic malignant syndrome (NMS) following treatment with olanzapine (20 mg per day), an atypical antipsychotic drug. NMS is usually seen with typical antipsychotic drugs. The patient was diagnosed as a case...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3608309/ https://ncbi.nlm.nih.gov/pubmed/23543750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.106448 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|